Celestica director granted 142 restricted share units

Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.

CELESTICA INC reported that director Amar Maletira received a grant of 142 Director Restricted Share Units (D-RSUs) on August 11, 2026. Each D-RSU represents a contingent right to receive one common share or an equivalent cash value upon settlement, subject to any deferral election. These D-RSUs vest on May 20, 2027, bringing Maletira’s directly held D-RSU balance to 781 units following this grant.

Insider Trade Summary

Grant/Award: 142 shares

Grant/Award 1 txn

Insider Maletira Amar

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Director Restricted Share Units F1, F2	142	$0.00	$0.00

Holdings After Transaction: Director Restricted Share Units — 781 contracts (Direct)

Footnotes (2)

1. F1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.
2. F2. On August 11, 2026, the reporting person was granted 142 D-RSUs, which vest on May 20, 2027.

Key Figures

D-RSUs granted: 142.0000 units D-RSUs held after grant: 781.0000 units Transaction price per unit: $0.0000 +1 more

4 metrics

D-RSUs granted 142.0000 units Director Restricted Share Units granted on August 11, 2026

D-RSUs held after grant 781.0000 units Total Director Restricted Share Units directly held following the transaction

Transaction price per unit $0.0000 Per-unit price reported for the 142 D-RSUs granted

Vesting date May 20, 2027 Vesting date for the 142 Director Restricted Share Units

Key Terms

Director Restricted Share Units, contingent right, deferral election

3 terms

Director Restricted Share Units financial

"Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share"

contingent right financial

"represents a contingent right to receive one common share upon settlement"

deferral election financial

"upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CELESTICA INC (CLS) disclose about Amar Maletira’s latest equity award?

CELESTICA INC disclosed that director Amar Maletira was granted 142 Director Restricted Share Units on August 11, 2026. These units vest on May 20, 2027 and increase his directly held D-RSU balance to 781 units.

How many Director Restricted Share Units did Amar Maletira receive from CLS?

Amar Maletira received 142 Director Restricted Share Units from CELESTICA INC. Each unit is a contingent right to one common share or equivalent cash upon settlement, subject to his deferral election and the vesting schedule.

When do Amar Maletira’s new CELESTICA INC D-RSUs vest?

The newly granted 142 D-RSUs to Amar Maletira vest on May 20, 2027. After vesting, each unit can settle into one common share or equivalent cash value, based on plan terms and any deferral election.

What is Amar Maletira’s total D-RSU holding in CLS after this grant?

Following the August 11, 2026 grant, Amar Maletira holds 781 Director Restricted Share Units directly. This total includes the newly awarded 142 D-RSUs and represents his current reported D-RSU position as a director of CELESTICA INC.

Do the CELESTICA INC D-RSUs granted to Amar Maletira have a purchase price?

The filing shows a per-unit transaction price of $0.0000 for the 142 D-RSUs. As described, the units are an equity award granting a contingent right to receive one common share or equivalent cash upon settlement, subject to plan terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:47 PM Accepted by SEC EDGAR 08/12/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maletira Amar

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO M2N 6L7

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Restricted Share Units	(1)	08/11/2026		A		142		(2)	(2)	Common Shares	142	$0	781	D

Explanation of Responses:

1. Each director restricted share unit ("D-RSU") represents a contingent right to receive one common share upon settlement, subject to the reporting person's deferral election, or, at the Issuer's election, an equivalent value in cash.

2. On August 11, 2026, the reporting person was granted 142 D-RSUs, which vest on May 20, 2027.

	/s/ Tracy Connelly McGilley, attorney-in-fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)